3/10/22 - Pfizer Begins Testing Pill On Kids

file image - Pfizer

Pfizer begins testing their COVID-19 pill in high risk children ages 6-17 years-old.

On Wednesday Pfizer announced that they have started a clinical trial testing of their antiviral pill in children as young as 6.

Pfizer is looking to enroll some 140 participants in the trial for the drug called Paxlovid.

The company says the pillcan safely treat Covid in children who are at risk of becoming severely ill.

The pills need to be taken early to be effective — within five days of symptom onset.

Paxlovid has already been authorized for people ages 12 and older.

The children in the trial will be divided into two groups to determine what type of dosage they would receive.

The company also said it expects to enroll children under age 6 once its scientists have finished developing an appropriate formulation of the pill.

Trial locations include Mississippi, South Carolina and Texas, according to clinicaltrials.gov.

 

 

More from National

On Air Now Music with Susan
Let It Begin Big Daddy Weave 1:50pm
Hold On Katy Nichole 1:46pm
Encouraging Words From Your Bible

So now there is no condemnation for those who belong to Christ Jesus. And because you belong to him, the power of the life-giving spirit has freed you from the power of sin that leads to death.

ROMANS 8:1-2 | NLT
Family-Friendly Commercial-Free
91.3 WCSG
Grand Rapids / Lakeshore
88.3 WCXK
Kalamazoo
90.9 WCFG
Battle Creek
89.9 WCXB
Benton Harbor